Harvard

This is your central portal for breaking news, the latest research and important updates from $name. Bookmark this page and check back often for updates.

Cover Story

New use for an old drug: The potential of colchicine in CVD

Cardiology Today, January 2020
Secondary prevention of CVD with colchicine is a major focus for the cardiology community, especially after recent presentations of the COLCOT and…

Key opinion leaders discuss top news from 2019

Cardiology Today, January 2020
Approximately 50% of high school students are vaping. The major product in these devices is nicotine, one of the most addicting substances known. As…
Feature

Minority patients value, but are less likely to see, oncologists who understand their culture

January 8, 2020
The existence of racial
Meeting News

New gene therapy appears safe, feasible for sickle cell disease

December 26, 2019
ORLANDO — Significant induction of fetal hemoglobin after the infusion of CD34-positive cells occurred among a small cohort of patients with…
Meeting NewsPerspective

Anastrozole provides long-term preventive effect for postmenopausal women at high risk for breast cancer

December 16, 2019
SAN ANTONIO — Anastrozole reduced breast cancer risk by 49% compared with placebo for postmenopausal women at high risk for the disease…
Meeting NewsPerspective

Accelerated partial breast irradiation effectively prevents recurrence in early breast cancer

December 13, 2019
SAN ANTONIO — Accelerated partial breast irradiation after surgery appeared as effective as whole breast irradiation for preventing recurrence…
Meeting NewsPerspective

Three-agent regimen effective, safe in high-risk smoldering multiple myeloma

December 9, 2019
ORLANDO — The combination of ixazomib, lenalidomide and dexamethasone appeared highly effective for patients with high-risk smoldering myeloma…
Meeting NewsPerspective

Front-line acalabrutinib regimen appears safe, induces complete response in chronic lymphocytic leukemia

December 7, 2019
ORLANDO — The combination of acalabrutinib, venetoclax and obinutuzumab demonstrated high rates of complete response and undetectable minimal…
In the Journals

Omega-3 supplementation fails to reduce risk for colorectal cancer precursors

November 26, 2019
Omega-3 supplementation of 1 g per day did not appear to reduce the risk for colorectal cancer precursors among the average-risk U.S. population…

Trial of KD025 for chronic GVHD meets primary endpoint at interim analysis

November 12, 2019
A pivotal trial designed to assess KD025 for patients with pretreated chronic graft-versus-host disease met its primary endpoint of overall response…
Meeting News

Researchers to be honored at San Antonio Breast Cancer Symposium

October 31, 2019
The San Antonio Breast Cancer Symposium and American Association for Cancer Research — one of the conference’s co-sponsors — will…

Hematologists, oncologists elected to National Academy of Medicine

October 30, 2019
The National Academy of Medicine announced the election of 90 regular members and 10 international members. Election to the academy —…
Healio Hot Topic

Many Options Available for Patients With Refractory IBS

Healio Gastroenterology, October 2019
Anthony J. Lembo, MD
By the time a patient with irritable bowel syndrome gets to a tertiary referral physician like me, they have likely tried a lot of treatments…
Cover Story

Catheter ablation for AF: Debate continues over benefit

Cardiology Today, October 2019
The debate on the use of catheter ablation in patients with atrial fibrillation has intensified among cardiologists after results of the anticipated…
In the Journals

Nivolumab-bevacizumab combination safe, active in relapsed ovarian cancer

October 11, 2019
A combination of nivolumab and bevacizumab appeared safe and induced responses among women with relapsed ovarian cancer, according to results of a…

Researchers share Nobel Prize for discoveries that may improve treatment of cancer, anemia

October 7, 2019
Three scientists — two from the United States and one from England — the Nobel Prize in Medicine or Physiology for their discoveries of…
In the Journals

Avelumab active in mismatch repair-deficient endometrial cancer

October 3, 2019
Avelumab induced promising activity among women with mismatch repair-deficient endometrial cancer regardless of PD-L1 status, according to results of…
In the Journals

Proton beam radiation therapy safe, effective for certain patients with breast cancer

October 2, 2019
Proton beam radiation therapy for breast cancer appeared safe and conferred similar rates of disease control compared with historical data of…
Meeting News

Addition of M6620 to gemcitabine prolongs PFS in platinum-resistant ovarian cancer

September 29, 2019
BARCELONA, Spain — The addition of the ATR kinase inhibitor M6620 to gemcitabine extended PFS without additional toxicity among patients with…
Cover Story

New research, recent controversies question vitamin D benefits in CVD

Cardiology Today, September 2019
The idea of “sunshine in a bottle” — vitamin D supplementation — has been promoted as a possible fix for everything from bone…